Barcelona, August 25, 2021. Multiple myeloma (MM), although relatively rare, is a highly heterogeneous cancer accounting for around 10% of…
Barcelona, August 24, 2021. Launched back in 2016 by Spanish Association against Cancer (AECC), and organized in collaboration with the…
Barcelona, August 02, 2021. The BRCA1 and BRCA2 genes are crucial actors in the DNA damage response and repair pathway;…
Following her debut column as author of ESMO Perspectives’ On target, Elena Garralda, Principal Investigator of our Early Clinical Drug Development…
Promoted by the +MIR Spanish Society of Medical Oncology (SEOM) Residents and Young Oncologists Committee, a study published in ESMO…
Barcelona, July 27, 2021. Recently published ahead of print in Clinical Cancer Research (1), a CCR Translations article co-authored by…
Research led by VHIO investigators represents a step forward in better understanding the underlying mechanisms that drive disease progression in…
Barcelona, June 23, 2021. Published today in the Journal of Cell Biology, a Perspective article* co-authored by VHIO’s Laura Soucek and Jonathan R. Whitfield revisit…
Announced today, the PEGASUS study will assess circulating tumor DNA in blood to identify micrometastases in patients with colon cancer….
Barcelona, June 18, 2021. VHIO’s MYC ‘Masters’, Laura Soucek and Jonathan Whitfield, have shared their expertise alongside other leading figures in…
Barcelona, June 15, 2021 – ESMO Perspectives is the bi-monthly digital magazine of the European Society for Medical Oncology (ESMO), edited by…
Announced this week by the SOLTI academic Breast Cancer Research Group, the ACROPOLI phase II open-label single arm, non-randomized, multicenter…
